M. K. Andrade

Outcomes from patients with presumed drug resistant tuberculosis in five reference centers in Brazil

A. Kritski, P. Fujiwara, P. Phillips, 2017, BMC Infectious Diseases.

Genetic Diversity and Molecular Epidemiology of Mycobacterium tuberculosis in Roraima State, Brazil.

A. Kritski, J. R. Lapa e Silva, M. Viveiros, 2019, The American journal of tropical medicine and hygiene.

Phenotypic and genotypic variant of MDR-Mycobacterium tuberculosis multiple isolates in the same tuberculosis episode, Rio de Janeiro, Brazil.

M. Saad, M. K. Andrade, M. L. Leite, 2009, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Clinical Evaluation of the Microscopic Observation Drug Susceptibility Assay for Detection of Mycobacterium tuberculosis Resistance to Isoniazid or Rifampin

R. Chaisson, S. Dorman, A. Kritski, 2007, Journal of Clinical Microbiology.

[Multiresistant tuberculosis in Brazil: history and control].

M. Dalcolmo, P. D. Picon, M. K. Andrade, 2007, Revista de saude publica.

Retreatment tuberculosis cases. Factors associated with drug resistance and adverse outcomes.

L. Riley, A. Kritski, E. Werneck-Barroso, 1997, Chest.

Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis.

R. Chaisson, S. Dorman, A. Kritski, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil.

A. Kritski, A. Kritski, F. Mello, 2010, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Clinical Impact of the Line Probe Assay and Xpert® MTB/RIF Assay in the Presumptive Diagnosis of Drug-Resistant Tuberculosis in Brazil: A Pragmatic Clinical Trial

A. Kritski, I. Langley, S. Squire, 2022, Revista da Sociedade Brasileira de Medicina Tropical.